Latest in Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Sort by
2,452 items
-
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in payments and royalties on sales.CNBC - 7h -
Govee Discount Codes and Deals: Up to 50% Off
For a limited time, score up to 50% off smart appliances when you shop this holiday season at Govee.Wired - 15h -
Databricks Is Raising $10 Billion, in One of the Largest Venture Capital Deals
The artificial intelligence start-up’s funding shows investors remain enthusiastic about the A.I. boom.The New York Times - 1d -
Carlsberg Cleared to Proceed With $4.2 Billion Britvic Deal
Carlsberg announced plans in July to buy the U.K. soft drinks giant, in a move to develop its Nordic bottling business and strengthen its presence in Western Europe.The Wall Street Journal - 1d -
Alibaba Expects to Book $1.28 Billion Loss on Sale of Department Store
The sale comes as Alibaba has been restructuring its businesses to focus on the e-commerce sector amid intensifying competition with its Chinese rivals.The Wall Street Journal - 1d -
FDA warns companies over unapproved weight loss drug sales
The Food and Drug Administration (FDA) said Tuesday in a statement it has sent warning letters to companies selling unapproved weight loss drugs. The letter went to Xcel Peptides, Swisschems, ...The Hill - 6h -
Democrats have learned nothing from their election loss
Instead of listening to demoralized and frustrated Democratic voters, the party elders chose to protect leadership that has lost the confidence of the people. If the party has learned a lesson from ...The Hill - 8h -
Tennessee woman accused of selling fake weight loss drugs as counterfeit concerns grow
A Tennessee woman was accused of selling counterfeit versions of popular weight loss drugs including Ozempic. Experts say fakes have exploded in the U.S.NBC News - 1d -
Why the investor craze for Ozempic and rival weight-loss drugs may resume next year
Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance of GLP agonists in 2025, Barclays analysts saidMarketWatch - 2d -
Saving England’s Music Oasis From a New Wave of Development
The working-class city of Manchester has birthed legendary bands for decades. But in its quest for growth, its musical legacy is in danger of being muted.The New York Times - 4d -
-
A suspected Chinese spy with business ties to Prince Andrew is barred from UK
A suspected Chinese spy with business ties to Prince Andrew has been barred from the United Kingdom because of concerns that he posed a threat to national securityABC News - 5d -
Alleged Chinese Agent With Links to Prince Andrew Is Barred From U.K.
The Chinese businessman has been banned from entering the U.K. after intelligence services alleged he was trying to influence the British royal on behalf of Beijing.The Wall Street Journal - 5d -
Suspected Chinese spy with business ties to Prince Andrew barred from UK
A suspected Chinese spy with business ties to Prince Andrew has been barred from the U.K. because of concerns he posed a threat to national securityABC News - 5d -
In shift, RFK Jr. now says weight-loss drugs 'have a place'
His remarks come days before he holds confirmation meetings with GOP senators.ABC News - 5d -
Alleged Chinese spy linked to Prince Andrew excluded from the UK
Immigration hearing rules businessman had ties to prominent Britons that could be ‘leveraged for political interference’Financial Times - 6d -
Elon Musk contradicts RFK Jr.'s sentiments on weight loss drugs
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.ABC News - 6d -
What other conditions could weight-loss drugs treat?
Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’sFinancial Times - 6d -
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
It is made possible through a first-of-a-kind integration with Eli Lilly's direct-to-consumer website, and aims to streamline access to the popular treatment.CNBC - Dec. 11 -
From 'Fortnite' to 'Hogwarts Legacy': One university fuels Utah's $2 billion video game industry
Utah's video game industry has surged more than 230% in a decade and added an estimated $2.6 billion to the state's economy in 2024.CNBC - Dec. 10 -
Gen Digital to Acquire MoneyLion in Deal Worth $1 Billion
Gen, which provides security, storage and systems management through brands such as Norton and Lifelock, said it will pay $82 a share in cash to acquire the digital financial-services and ...The Wall Street Journal - Dec. 10 -
Some health experts warn against microdosing weight loss drugs
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some ...CBS News - Dec. 9 -
Taylor Swift’s Eras Tour Made a Record $2 Billion of Ticket Sales
Over 21 months, the pop superstar’s culture-dominating stage show doubled the gross of its closest competitor, according to ticket sales figures confirmed for the first time.The New York Times - Dec. 9 -
Boliden to Buy Swedish, Portuguese Mines From Lundin Mining for Up to $1.45 Billion
The Swedish company said it has agreed to buy the Neves-Corvo mine in Portugal and the Zinkgruvan mine in Sweden in a deal to boost its copper and zinc production.The Wall Street Journal - Dec. 9 -
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.CNBC - Dec. 8 -
Weight-loss drug Mounjaro 'changed my life,' says mother-of-two
People struggling with their weight welcome the NHS rollout of Mounjaro but worry about delays.BBC News - Dec. 5 -
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.CNBC - Dec. 5 -
Millions will have to wait up to 12 years for NHS weight-loss drug
Fears that giving 3.4 million people immediate access to new weight-loss drug could overwhelm NHS.BBC News - Dec. 5 -
Will Trump nix Biden’s coverage plan for weight-loss drugs? It’ll be a close call.
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says it’s possible he could end up supporting the Democratic incumbent’s ...MarketWatch - Dec. 4 -
Zepbound brings more weight loss than Wegovy: Drugmaker
Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from their ...The Hill - Dec. 4 -
Why Another Stalker 2 Delay Was Never An Option For Its Ukrainian Developer
Stalker 2: Heart of Chornobyl --the long-awaited sequel to developer GSC Game World's 2007 classic --was delayed several times during development, with an initial announcement in 2010 and a launch ...GameSpot - Dec. 4 -
FIFA Secures $1 Billion Broadcast Deal With DAZN for Club World Cup
An agreement with the London-based streaming company DAZN came just a day before the draw for the inaugural event and after other networks balked at FIFA’s demands.The New York Times - Dec. 4 -
G.M.’s Ailing China Business Will Deal It a $5 Billion Blow
General Motors and other foreign automakers are selling fewer cars and losing lots of money in China, where domestic electric and hybrid cars have taken off.The New York Times - Dec. 4 -
Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy
Zepbound helped patients lose more weight than a major rival in a head-to-head trial.MarketWatch - Dec. 4 -
A rival weight loss drug to Wegovy helped people shed more pounds, study shows
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.NBC News - Dec. 4 -
Stalker 2 Developer Explains Why A-Life 2.0 Was Pulled From The Game's Description
Stalker 2: Heart of Chornobyl has only been out for two weeks, but the game remains a work in progress. Developer GSC Game World released a day-one patch to address some of Stalker 2's lingering ...GameSpot - Dec. 4 -
From Chinese Patriot to American Spy: The Unusual Life of John Leung
He had been hailed by Chinese state media as a model for his efforts to promote Beijing’s interests in the United States. He was in fact an F.B.I. informant.The New York Times - Dec. 4 -
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Zepbound's greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.CNBC - Dec. 4 -
Experts create controllable gastric balloon to aid weight loss
Device inflates before eating and contracts afterwards, simulating the effects of having a meal, say scientists. From weight loss jabs to vibrating pills , the obesity crisis has spawned myriad ...The Guardian - Dec. 3 -
Americans expected to spend $13 billion total on Cyber Monday deals
Consumers are focusing on finding deals on Cyber Monday and American spending is expected to rise compared to 2023. CBS MoneyWatch correspondent Kelly O'Grady breaks down the spending trends for 2024.CBS News - Dec. 2
